Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 11
2019 12
2020 18
2021 16
2022 14
2023 10
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update.
Smith CH, Yiu ZZN, Bale T, Burden AD, Coates LC, Edwards W, MacMahon E, Mahil SK, McGuire A, Murphy R, Nelson-Piercy C, Owen CM, Parslew R, Uthman OA, Woolf RT, Manounah L, Ezejimofor MC, Exton LS, Mohd Mustapa MF; British Association of Dermatologists’ Clinical Standards Unit. Smith CH, et al. Br J Dermatol. 2020 Oct;183(4):628-637. doi: 10.1111/bjd.19039. Epub 2020 Jul 21. Br J Dermatol. 2020. PMID: 32189327 No abstract available.
Severe allergic eye disease: What to do and when?
Dahlmann-Noor A, Muthusamy K, Hingorani M. Dahlmann-Noor A, et al. Clin Exp Allergy. 2021 Aug;51(8):989-991. doi: 10.1111/cea.13985. Clin Exp Allergy. 2021. PMID: 34337807 No abstract available.
An international patient-centred study of retroperitoneal fibrosis.
Dattani R, Barwick TD, El Wardany G, Gibbons N, Mason JC, Morgan P, Pusey CD, Tam FWK, Tomlinson JAP; RaDaR Rare Disease Group (RDG). Dattani R, et al. QJM. 2022 Mar 22;115(3):148-154. doi: 10.1093/qjmed/hcaa327. QJM. 2022. PMID: 33377941
IgE Antibodies against Cancer: Efficacy and Safety.
Chauhan J, McCraw AJ, Nakamura M, Osborn G, Sow HS, Cox VF, Stavraka C, Josephs DH, Spicer JF, Karagiannis SN, Bax HJ. Chauhan J, et al. Antibodies (Basel). 2020 Oct 16;9(4):55. doi: 10.3390/antib9040055. Antibodies (Basel). 2020. PMID: 33081206 Free PMC article. Review.
Rationale for targeting complement in COVID-19.
Polycarpou A, Howard M, Farrar CA, Greenlaw R, Fanelli G, Wallis R, Klavinskis LS, Sacks S. Polycarpou A, et al. EMBO Mol Med. 2020 Aug 7;12(8):e12642. doi: 10.15252/emmm.202012642. Epub 2020 Jul 12. EMBO Mol Med. 2020. PMID: 32559343 Free PMC article. Review.
Invited Review: The spectrum of neuropathology in COVID-19.
Al-Sarraj S, Troakes C, Hanley B, Osborn M, Richardson MP, Hotopf M, Bullmore E, Everall IP. Al-Sarraj S, et al. Neuropathol Appl Neurobiol. 2021 Feb;47(1):3-16. doi: 10.1111/nan.12667. Epub 2020 Oct 20. Neuropathol Appl Neurobiol. 2021. PMID: 32935873 Review.
65 results